(Q36871396)

English

ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells

scientific article published on 4 May 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

invasive ductal carcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal adenocarcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Hiroto Fukushima

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Makiko Yasumoto

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sachiko Ogasawara

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jun Akiba

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Yuhei Kitasato

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Masamichi Nakayama

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Yoshiki Naito

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Yusuke Ishida

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Yoshinobu Okabe

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Masafumi Yasunaga

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Hiroyuki Horiuchi

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Etsuko Sakamoto

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Hiraku Itadani

13

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Shinji Mizuarai

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Shinji Oie

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Hirohisa Yano

16

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

4 May 2016

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Molecular Cancer

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

32

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Prognostic value of microRNA expression in operable non-small cell lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Rho/Rho-associated kinase pathway in glaucoma (Review).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Characterization of a Cdc42 protein inhibitor and its use as a molecular probe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42 activation and potentiating RhoJ inactivation in endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Coordinated RhoA signaling at the leading edge and uropod is required for T cell transendothelial migration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Targeting rho GTPases by peptidic structures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

VAV1: a new target in pancreatic cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

RHO-GTPases and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Rho GTPases in cell biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

The role of Rho GTPases in disease development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

29 September 2017

Control of axon elongation via an SDF-1alpha/Rho/mDia pathway in cultured cerebellar granule neurons.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

27 June 2018

Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

27 June 2018

Pancreatic Adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

4 September 2018

Pancreatic Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

4 September 2018

Clear cell carcinoma of the pancreas: histopathologic features and a unique biomarker: hepatocyte nuclear factor-1beta.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

4 September 2018

Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

4 September 2018

Rho family proteins and Ras transformation: the RHOad less traveled gets congested.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4857279

4 September 2018

RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta

1 reference

https://pubmed.ncbi.nlm.nih.gov/27145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of RhoA in progression of human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27145964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12943-016-0516-4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36871396&oldid=2199478313"